Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. J Clin Oncol. 2020 03 01; 38(7):674-685.